American Society of Hematology

Continuing Conversations With the Speakers

Please check back next week for a more detailed preliminary schedule and program.

Continuing Conversations With the Speakers sessions offer additional informal and interactive discussions to supplement the traditional didactic Q&A format of Scientific Program sessions.

These sessions are available on a first-come, first-served basis and are intended to give interested individuals, especially trainees and junior investigators, increased accessibility both to information on the topic and to the opinions of experts in those fields. Attendees should come prepared to actively participate in the discussions.

Continuing Conversations Session at the ASH Annual Meeting

Continuing Conversations With the Speakers on Metabolism and Hematologic Malignancies

Join Drs. Tak Mak, Marina Konopleva, Aaron Schimmer, and Stefano Casola to continue discussions on the role of metabolism in the onset and progression of hematologic diseases, as well as the development of novel therapeutic approaches. This session complements the joint Scientific Program session titled “Metabolism and Hematologic Malignancies” and provides an increased opportunity for scientific peers to form collaborations and partnerships.

Co-Chairs:

Ravi Majeti, MD, PhD
Stanford University School of Medicine
Stanford, CA

Inga Hofmann, MD
University of Wisconsin
Madison, WI

Speakers:

Aaron Schimmer, MD, PhD
Princess Margaret Hospital, University of Toronto
Toronto, ON, Canada

Stefano Casola, MD, PhD
FIRC Institute of Molecular Oncology Foundation
Milan, Italy

Tak Mak, PhD, DSc
Princess Margaret Cancer Center
Toronto, ON, Canada

Marina Y. Konopleva, MD, PhD
The University of Texas MD Anderson Cancer Center
Houston, TX

back to top

Continuing Conversations With the Speakers on Role and Mechanisms of Clonal Evolution in Lymphoid Malignancies

Join Drs. Charles Mullighan, Dan Landau, and Sarah-Jane Dawson to continue a discussion on the implications of clonal evolution, including the role of genetic and epigenetic heterogeneity on the development of lymphoid malignancies. This session complements the Scientific Program session titled “Role and Mechanisms of Clonal Evolution in Lymphoid Malignancies” and provides an increased opportunity for scientific peers to form collaborations and partnerships.

Chair:

Christian Steidl, MD
British Columbia Cancer Agency
Vancouver, BC, Canada

Speakers:

Charles G. Mullighan, MBBS, MD
St. Jude Children's Research Hospital
Memphis, TN

Dan A. Landau, MD, PhD
Weill Cornell Medical College
New York, NY

Sarah-Jane Dawson
Peter MacCallum Cancer Center
Melbourne, Australia

back to top

Continuing Conversations With the Speakers on Swinging the Iron Pendulum: Loss and Gain Through Blood Donation and Transfusion

Join Drs. Laura Silvestri, Caroline Philpott, Eldad Hod, and Alan Mast to continue discussions on iron physiology and the clinical implications of blood transfusion and blood donation on iron homeostasis. This session complements the joint Scientific Program session titled “Swinging the Iron Pendulum: Loss and Gain Through Blood Donation and Transfusion.” It provides an opportunity for scientific discourse and the formation of vital collaborations and partnerships.

Chairs:

Jeanne E. Hendrickson, MD
Yale University
Guilford, CT

Karin E. Finberg, MD, PhD
Yale School of Medicine
New Haven, CT

Speakers:

Laura Silvestri, PhD
San Raffaele Scientific Institute & Vita-Salute Uni.
Milan, Italy

Eldad A. Hod, MD
Columbia University Medical Center
New York, NY

Caroline Philpott
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
Bethesda, MD

Alan E. Mast, MD,PhD
Blood Center of Wisconsin
Milwaukee, WI

back to top

Continuing Conversations With the Speakers on Thrombopoiesis Revised: From Lung to Hematopoietic Stem Cell Platelet Bias

Join Drs. Mark Looney, Katrin Heinze, and Claus Nerlov to continue discussion on platelet biogenesis and the possible role that age-related platelet bias could have on bone marrow transplantation. This session complements the Scientific Program session titled “Thrombopoiesis Revised: From Lung to Hematopoietic Stem Cell Platelet Bias.” The session provides an increased opportunity for scientific discourse and the formation of vital collaborations and partnerships.

Chair:

Jordan A. Shavit, MD,PhD
University of Michigan
Ann Arbor, MI

Speakers:

Claus Nerlov, PhD
Oxford University
Oxford, United Kingdom

Mark Looney
University of California – San Francisco
San Francisco, CA

Katrin G Heinze
University of Würzburg
Würzburg, Germany

Other Scientific Sessions

back to top